Hard Numbers: US brings pharma home, sports fans root for vaccine, militants attack in Pakistan

354 million: The Trump administration has signed a $354 million contract with a new biomedical company in the US state of Virginia to make pharmaceutical ingredients that are currently manufactured overseas. The administration has hailed the deal as part of a move to bring more of the pharmaceutical supply chain back to the United States.

54: Sports fans may be starved for action, with most major leagues on hold because of coronavirus, but 54 percent of respondents in a recent poll conducted in the UK, US, Australia, and South Africa said resumption of live events should wait until a vaccine is available. Asked separately whether events should go on before then without fans in attendance, 37 percent said yes.

7: Militants in Pakistan's restive southwestern Balochistan province killed seven government soldiers in two separate attacks on Tuesday. No one has claimed responsibility, but Balochistan, rich in minerals and a focus of China's Belt and Road Initiative, has a long history of ethnic separatist insurgency.

28 million: As the world's health systems divert most of their attention to coronavirus, as many as 28 million elective surgeries could end up postponed, according to a new University of Birmingham study. While most are for benign conditions, more than 2 million are for cancer.

More from GZERO Media

U.S. President Donald Trump speaks with Democratic Republic of the Congo's Foreign Minister Therese Kayikwamba Wagner and Rwanda's Foreign Minister Olivier Nduhungirehe on June 27, 2025.
REUTERS

On June 27, the Democratic Republic of Congo and Rwanda signed a US-mediated peace accord in Washington, D.C., to end decades of violence in the DRC’s resource-rich Great Lakes region. The agreement commits both nations to cease hostilities, withdraw troops, and to end support for armed groups operating in eastern Congowithin 90 days.

What if the next virus isn’t natural, but deliberately engineered and used as a weapon? As geopolitical tensions rise and biological threats become more complex, health security and life sciences are emerging as critical pillars of national defense. In the premiere episode of “The Ripple Effect: Investing in Life Sciences”, leading experts explore the dual-use nature of biotechnology and the urgent need for international oversight, genetic attribution standards, and robust viral surveillance.

A woman lights a cigarette placed in a placard depicting Hungary's Prime Minister Viktor Orbán, during a demonstration, after the Hungarian parliament passed a law that bans LGBTQ+ communities from holding the annual Pride march and allows a broader constraint on freedom of assembly, in Budapest, Hungary, on March 25, 2025.
REUTERS/Marton Monus

Hungary’s capital will proceed with Saturday’s Pride parade celebrating the LGBTQ+ community, despite the rightwing national government’s recent ban on the event.